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revealed that the majority of changes occurred between Days 10 and 12 of SEP. To
compare transcript levels between CG-rescued and regressing CL, previously banked
rhesus GeneChip array data (NCBI GEO Series GSE10367) from CL collected
during the mid- to late and very late luteal phase were analyzed with time-matched
intervals in SEP. Comparing RMA-normalized transcripts from the natural cycle
(Group 1, CL days 10, 12, 14-16, and 18-19) with those from luteal rescue (Group 2,
hCG-treated samples) revealed 7677 transcripts changing in expression pattern .2-
fold (one-way ANOVA, FDR correction; P,0.05) between the two groups.
Clustering of samples revealed that the SEP samples possessed the most related
transcript expression profiles. Regressed CL (days 18-19, around menses) were the
most unlike all other CL. KEGG analysis indicated the most affected pathway was
Steroid Biosynthesis; an acute stimulatory response to hCG during SEP was observed
for HSD3beta2 and CYP19 mRNA, whereas a chronic stimulatory response occurred
for StAR, CYP11A1, CYP17A1, and LHCGR mRNA as measured by real-time PCR.
Acute stimulation by CG was noted for PGR, and GCRa mRNA, while acute
inhibition by CG was measured for VEGF, CRHBP and 11bHSD2 mRNA. Chronic
stimulation was detected for RLN1, CAT, and PGRMC1 mRNA; while message for
11bHSD1 was chronically inhibited during SEP. Transcript levels for the
prostaglandin F2a receptor PTGFR, which are up-regulated during luteolysis, were
mostly down-regulated by SEP treatment. The most significantly absent pathway
(negative z-score) following SEP treatment includes a group of genes whose products
promote cell-death. By further comparing the genome-wide changes in luteal gene
expression during rescue in SEP, with those in CL during luteolysis in the natural
menstrual cycle, it is possible to identify key regulatory pathways promoting fertility.
R01 HD20869, RR00163, T32-HD07133 (CVB), China Scholarship Council (CSC;
LX).
128. Liver X Receptor Modulation of Gene Expression Leading to Pro-
Luteolytic Effects in Primate Luteal Cells. Randy L. Bogan and Jon D.
Hennebold. Oregon Health & Science University, Oregon National Primate Research
Center, Beaverton, OR, USA
The expression of genes necessary for reverse cholesterol transport (RCT) and
cholesterol metabolism is controlled by the liver x receptors (LXR) alpha and beta,
members of the nuclear hormone receptor superfamily. Previously, we reported an
acute induction of RCT component expression occurs (mRNA and protein)
coinciding with the fall in progesterone (P4) synthesis at the end of the luteal phase
(i.e., functional regression) in the rhesus macaque corpus luteum (CL). Additionally,
we identified three endogenous LXR ligands (22R-hydroxycholesterol and 27-
hydroxycholesterol, or 22ROH and 27OH, respectively; and desmosterol) that are
present in the CL during the luteal phase. Therefore, LXR regulation of gene
expression may be a key determinant of functional regression in the primate CL. To
test this hypothesis, we used dispersed primate luteal cell cultures obtained from mid-
luteal stage CL (days 7-8 post LH-surge, peak P4 production) to determine whether
synthetic and endogenous LXR ligands: 1) increase expression of known LXR target
genes, 2) inhibit expression of cholesterol uptake and steroidogenic genes, and 3)
increase cholesterol efflux. The well characterized synthetic LXR agonist T0901317
(T09, 1 lM) as well as the endogenous ligands 22ROH, 27OH, and desmosterol (1 or
5 lM, physiologic range) were incubated with luteal cells for 24 hr. To facilitate
uptake of sterols, 0.5% (w:v) beta-cyclodextrin (beta-CDX) was added to the culture
media. T09 caused significant (p,0.05) increases compared to vehicle in mRNA
levels of known LXR target genes including the cholesterol efflux proteins ATP
binding cassette subfamily A1 (ABCA1), and G1 (ABCG1), as well as LXRalpha itself
(n = 8). T09 also caused a significant decrease in 3beta-hydroxysteroid
dehydrogenase (HSD3B2) mRNA compared to vehicle (p,0.05), but had no effect
on low and high density lipoprotein receptors, or steroidogenic acute regulatory
protein expression. Surprisingly, beta-CDX itself caused a significant (p,0.05)
decrease in ABCA1, ABCG1, and LXRalpha expression in vehicle-treated cells. As
beta-CDX is known to deplete cells of sterols, this indicates that there is a high degree
of basal LXR gene expression controlled by endogenous sterols. LXR target gene
responsiveness to the endogenous ligands varied between luteal preparations. When
replicates were divided based on initial LXRalpha mRNA levels (as an indicator of
endogenous LXR activity), the 4 cultures with the lowest basal LXRalpha expression
had significant (p, 0.05) increases in ABCA1 and/or ABCG1 mRNA levels in
response to endogenous ligand (5 lM) treatment. The cultures with the highest
LXRalpha levels did not respond to endogenous ligands with statistically significant
increases in LXR target gene expression, indicating that luteal cells with higher LXR
levels may be refractory to further stimulation. Cholesterol efflux assays were used as
a functional endpoint of LXR activation. T09 and the 5 lM doses of 22ROH, 27OH
and desmosterol significantly (p,0.05, n = 5) increased cholesterol efflux compared
to controls. Collectively, these data indicate that: 1) activation of LXR-mediated RCT
may inhibit luteal steroidogenesis by increasing cholesterol efflux and decreasing
HSD3B2 expression ultimately causing functional regression, and 2) there is a high
degree of basal LXR activity in the primate CL that may need to be repressed during
the luteal phase to maintain P4 synthesis. This research was supported by NICHD
R01-HD42000 and NCRR RR00163.
129. Factor(s) Secreted from Bovine Luteal Cells Alter Function of
Bovine T Lymphocytes. Koji Toyokawa and J.L. Pate. Pennsylvania State
University, State College, PA, USA
The overall goal of this research is to understand the function of the bovine
corpus luteum (CL), ultimately leading to improved reproductive efficiency in the
dairy industry. The specific research focus is to understand how T lymphocytes (T
cells) in the bovine CL are regulated during the estrous cycle. We hypothesized that T
cell function could be modified not only by cell-cell contact but also via secreted
factor(s) from the CL. There are two major protein secretory pathways, termed
conventional and unconventional secretory pathways. Most secreted proteins transit
through the ER-Golgi system (conventional secretion), whereas some secreted
proteins bypass the traditional secretory pathway (unconventional), and the latter
secretory pathways are not inhibited by brefeldin A (BFA). In order to test our
hypothesis, we utilized BFA to block secretion of conventionally secreted proteins,
which also results in upregulation of proteins secreted by unconventional pathways.
In this study, conditioned media from luteal cells alone (LC) and from luteal cells
treated with BFA (LC+BFA) were utilized to understand autocrine and/or paracrine
interactions between T cells and luteal cells. The primary objectives of this study
were to determine T cell responses and cytokine production stimulated by factor(s)
secreted from luteal cells. First, the efficacy of BFA in altering protein secretion by
luteal cells was examined. Secretion of IL-4, one of the conventionally secreted
cytokines, was significantly inhibited in LC+BFA compared to conditioned medium
from LC (50% reduction, P,0.01). Secondly, we determined if conditioned medium
from luteal cells would mediate T cell responses, and further examined if BFA-
restricted secretion would alter function of T cells. Conditioned media from LC and
LC+BFA significantly stimulated T cell proliferation compared to media alone with
or without BFA (P,0.01). In addition, LC+BFA-conditioned medium stimulated
even higher T cell proliferation than LC-conditioned medium alone (30% and 20%,
respectively, P,0.01). However, addition of PGF2a to the culture medium had no
additive or synergistic effect on T cell responses. Finally, we investigated if factor(s)
secreted from LC- and LC+BFA-conditioned media altered cytokine expression in T
cells. Gene expression of IL2, IL2R, IFNc and TGFb was examined in T cells
cultured in LC- or LC+BFA-conditioned medium. Unexpectedly, expression of IL2
was significantly downregulated in T cells cultured in LC- and LC+BFA-conditioned
media compared to medium alone (P,0.01), whereas expression of IL2R and IFNc
in T cells was not changed. However, expression of TGFb (anti-inflammatory
cytokine) in T cells was also downregulated in LC- and LC+BFA-conditioned media
(P=0.05 and 0.08, respectively). In conclusion, this study provides evidence that
autocrine and/or paracrine factor(s) are involved in activation of T cells by luteal
cells. Furthermore, it is speculated that different factor(s) may be secreted from luteal
cells via unconventional secretions, and factor(s) secreted from luteal cells stimulated
by BFA may have more potent stimulatory effects on T cell proliferation. However,
the exact molecular mechanisms and identification of luteal-derived factors to
modulate T cell functions remain unknown. This project was supported by National
Research Initiative Competitive Grant no. 2004-35203-14789 from the USDA
Cooperative State Research, Education, and Extension Service to JLP.
130. Olfactomedin 1 (Olfm 1) in Fallopian Tube May Modulate Tubal
Ectopic Pregnancy in Humans: Evidence from Immunohistochemistry and an
In Vitro Coculture Model. Suranga P. Kodithuwakku, William S.B. Yueng, Pak
Chung Ho, and Kai Fai Lee. The University of Hong Kong, Hong Kong, Hong Kong
SAR
Olfactomedins are secretary glycoprotein constituted in the extracellular matrix
(ECM) of various cell types. Recent studies suggested that Olfm-1 is down-regulated
during the window of implantation (WOI) in the human endometrium and up-
regulated in pathological condition like endometriosis and recurrent spontaneous
abortions. Ectopic pregnancy is a gynaecological emergency and fertility threatening
phenomenon which occurs in 1-2% of normal pregnancies and shows an increasing
trend. Yet, tubal ectopic pregnancy accounts for more than 98% of the cases and the
distal part of the fallopian tube accounts for 85-95% of all tubal pregnancies. Our
unpublished data demonstrated that the expressions of Olfms are steroid hormone-
dependent and Olfm-1 affects spheroid attachment onto endometrial epithelial cells in
vitro. In the present study, we investigated the spatiotemporal expression of Olfm-1
protein and the transcript of different isoforms (Olfm-1, -2, -3, and -4) in normal
Fallopian tubes and tubes with ectopic pregnancies from human samples.
Furthermore, an in-vitro-trophoblastic-spheroids and Fallopian-tube-epithelial-cells
co-culture model was developed to investigate the possible role of Olfm-1 in tubal
ectopic pregnancies using a human Fallopian tube epithelium cell line (OE-E6/E7)
and recombinant Olfm-1 protein. Olfm-1 mRNA in the ampullary region showed a
significantly lower level (p,0.05) at luteal phase (n=12) than the follicular phase
(n=15); whereas there was no significant difference in the infundibullary or isthmic
regions between the two phases.The Olfm-1 protein was strongly expressed in the
epithelium of the three regions in the human Fallopian tube. The expression of Olfm-
1 protein in the infundibulary region is significantly higher (p,0.05) than in the
isthmic and ampullary regions in both the follicular (H-SCORE=3.660.3 vs 2.560.3
vs 2.360.7, respectively, n=8) and luteal (H-SCORE=3.560.2 vs 2.460.5 vs
2.360.6, respectively, n=10) phases of the cycle. Interestingly, the ampullary tubal
ectopic sections (n=10) showed a significantly lower level of Olfm-1 expression in
the epithelium (H-SCORE=1.360.2 when compared to normal ampullae (p,0.05). A
trophoblastic-spheroids (JAr) and human-Fallopian-tube-epithelial-cell (OE-E6/E7)
co-culture system was established. Treatment of OE-E6/E7 with recombinant human
Olfm-1 for 24 hrs dose-dependently (0.01-1lg/ml) reduced JAr spheroids attachment
to the OE-E6/E7 monolayers when compared to the untreated controls. Furthermore,
activation of the Wnt-signalling pathway using Wnt3a or LiCl was associated with
reduced Olfm-1 expression in OE-E6/E7 and increased spheroids attachment to OE-
E6/E7 cells, suggesting a possible interaction of Olfm-1 with the Wnt-signalling
pathway in the tubal ectopic pregnancy. In sum, Olfm-1 in the human Fallopian tube
may function to reduce tubal ectopic embryo attachment. Activation of the Wnt-
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signaling pathway and down-regulation of Olfm-1 expression favour the spheroid/
embryo attachment onto human Fallopian tube epithelium. [This project is supported
in part by an RCG grant HKU7514/05M to PCH]
131. Potential Role of Wnt in Neonatal Uterine Development. Kanako
Hayashi, Shin Yoshioka, Edmund B. Rucker, Thomas E. Spencer, Paul S. Cooke,
Francesco J. DeMayo, John P. Lydon, and James A. MacLean. Southern Illinois
University School of Medicine, Carbondale, IL, USA; University of Kentucky,
Lexington, KY, USA; Texas A&M University, College Station, TX, USA; University
of Illinois at Urbana-Champaign, IL, USA; Baylor College of Medicine, Houston,
TX, USA
WNT genes encode secreted glycoproteins that control cell fate, mortality,
proliferation, differentiation, and tissue growth, and subsets (Wnt4, Wnt5a, and
Wnt7a) are involved in Mullerian duct patterning and differentiation during
embryonic development of the female reproductive tract. The present study
investigated potential role of Wnts during postnatal mouse uterine development,
because disruption of endometrial adenogenesis and mesenchymal specification and
differentiation can cause permanent fertility problems in the adult. The expression of
19 Wnt genes and 10 Fzd receptors was determined by RT-PCR. The spatial
expression patterns of the most highly expressed genes: Wn4, Wnt5a, Wnt7a, Wnt7b,
Wnt11, Wnt16, Fzd6 and Fzd10 were further examined by in situ hybridization in the
neonatal mouse uterus. Wnt4, Wnt5a and Wnt16 were localized in the endometrial
stroma, whereas Wnt7a, Wnt7b and Wnt11 were in the uterine epithelia of neonatal
mice. Exposure of mice to estrogen or progesterone during critical development
periods inhibits endometrial adenogenesis. Diethylstilbestrol (DES) or progesterone-
induced disruption of endometrial gland development was associated with reduction
or ablation of Wn4, Wnt5a, Wnt7a, Wnt11, Wnt16 and Fzd10 mRNA during
endometrial morphogenesis. Next, we have characterized postnatal uterine
morphogenesis by conditionally ablating the expression of Wnt11 in the uterine
epithelium of mouse after birth using progesterone receptor (PR) Cre knockin
mouse. To increase the efficiency in the production of homozygous null alleles and
to decrease the incidence of mosaic deletion, PRcre/+ Wnt11f/- mice were crossed
with PRcre/+Wnt11+/- mice to PR+/+Wnt11f/f mice. Wnt11d/d mice did not show
disrupted endometrial gland development, and adult Wnt11d/d mice had normal
estrus cycles and were fertile. However, we observed disorganized luminal
epithelium on postnatal (P) day 7 in Wnt11d/d mice, and levels of Wnt4, Wnt5a,
Wnt7a, Wnt7b and Wnt16 in neonatal uteri were decreased in Wnt11d/d mice
compared to those in Wnt11f/f mice. Interestingly, ablation of Wnt11 appears to
increase the numbers of endometrial glands on P21 and P28. Wnt7a was stimulated
on P14 and P21 in uteri of Wnt11f/f mice, whereas Wnt5a and Wnt16 were
suppressed by loss of Wnt11. These results implicate that temporal and spatial
expression of Wnts are critical factors for endometrial adenogenesis via autocrine
and paracrine effects on neonatal uterine development. Further, Wnt11 actions may
involve changes in the expression of other members of the Wnt system to regulate
uterine morphogenesis. Supported by NIH HD058222.
132. Steroidal Regulation of Uterine Macrophage Migration Inhibitory
Factor Expression Is Mediated via miRNA-451. Warren B. Nothnick and Caitlin
Healy. University of Kansas Medical Center, Kansas City, KS, USA
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine
which regulates cell proliferation, angiogenesis and immune cell trafficking. Within
the uterus, MIF is expressed primarily by uterine epithelial cells in a cycle stage-
dependent fashion. Despite characterization of the pattern of uterine MIF expression
in a variety of species, virtually no information exists on MIF regulation. As such, the
objective of this study was to examine steroidal regulation of Mif in the mouse uterus.
Two-month-old, ovariectomized female mice (N=6/treatment group/time point) were
treated with estrogen (E2; 1 lg/kg BW) or E2 + progesterone (P4; 2 mg/kg BW) then
sacrificed at 0, 4, 8, and 24h post steroid treatment. Uterine Mif was examined by
qRT-PCR, Western blot analysis, and immunohistochemical localization. E2 alone,
or plus P4, significantly (P,0.05) increased Mif mRNA expression at all time points.
Assessment of Mif protein revealed that in contrast to the effect on transcript
expression, E2 significantly decreased Mif protein expression by approximately 35%
and 65% at 4h and 8h post steroid treatment, respectively, while at 24h, Mif protein
levels were approximately 20% below 0h values. Mif localized primarily to luminal
and glandular epithelial cells with low stromal expression. The discordant pattern of
expression between transcript and protein suggested to us that uterine Mif expression
may be regulated by microRNAs (miRs). miR451 is a putative regulator of MIF
expression which we have shown to be regulated by E2 within the uterus in a pattern
that is inversely correlated to the pattern of Mif uterine protein expression. To test the
hypothesis that miR451 regulates Mif protein expression, we transfected human
endometrial epithelial cells (HES), with pre-miR-451 precursor, non-targeting
precursor (pre-miR-NT; negative control) or transfection buffer alone and assessed
miR451 transcript expression by qPCR while MIF protein expression was assessed
by Western analysis. Transfection with pre-miR-451 precursor resulted in a
significant increase in HES cell expression of mature miR451 which was associated
with a significant reduction in MIF protein expression. To further verify that miR451
targets the MIF 3’UTR, HES cells were co-transfected with a Renilla-MIF 3’UTR
vector containing the wild-type miR451 seed sequence or a Renilla-MIF 3’UTR
mutant vector (mutant miR451 seed sequence), a control vector containing firefly
luciferase, and either pre-miR-451 or pre-miR-NT precursors. HES cells co-
transfected with constructs which contained the wild-type 3’UTR and pre-miR-451
exhibited significantly less luciferase activity (Renilla normalized to firefly)
compared to cells co-transfected with the mutant 3’UTR and pre-miR-451. Cells
co-transfected with the mutant 3’UTR and either the pre-miR-451 or pre-miR-NT
precursors did not exhibit a significant change in luciferase activity compared to
controls. Collectively, these data are interpreted to suggest that miR451 is capable of
binding to the 3’UTR of MIF in vitro and suppressing luciferase reporter activity.
These observations, coupled with the MIF Western blot data strongly suggest that
MIF expression is regulated by miR451. In summary, we demonstrate for the first
time that E2 regulates uterine Mif expression and that this regulation appears to be
mediated in part by miR451.
133. Estrogen Action Is Required for Expression of MMP-26 in the
Secretory Phase of the Menstrual Cycle in Rhesus Macaques. Camila Contin
Diniz de Almeida Francia, Christopher S. Keator, Kunie Mah, Lindsay Ohm, and Ov
D. Slayden. Oregon National Primate Research Center, Oregon Health & Science
University, Beaverton, OR, USA
Matrix metalloproteinase 26 (MMP-26) is a novel matrilysin-like endopeptidase
that may play a role during embryo implantation, but our knowledge on MMP-26
regulation remains inadequate. In women, endometrial MMP-26 is up-regulated by
progesterone (P) during the early and mid secretory phase. However, MMP-26
expression is refractory to P stimulation in the late secretory phase and the
mechanism underlying MMP-26 down regulation is not known. In this study we
examined hormone regulation of MMP-26 in ovariectomized artificially cycled
rhesus macaques. The samples were obtained from animals assigned to other studies
at the Oregon National Primate Research Center. The animals were treated with a
controlled estradiol (E2) and P regimen to mimic the menstrual cycle. To stimulate
the artificial cycles an E2-releasing capsule was placed subcutaneously (SC) to
induce the proliferative phase and after 14 days of E2 priming, a P-releasing capsule
was placed SC to induce the secretory phase of the cycle. Removal of the P implant
on day 28 completed the cycles and stimulated menstruation on days 2-4 of the next
cycle. Endometrium was collected on cycle day 3 (menstruation), days 7 and 14
(proliferative phase), day 17 (early secretory phase; E2 +3 days of P), day 21 (mid
secretory phase; E2 +7 days of P), and day 28 (late secretory phase; E2 +14 days of
P). In 3 animals, E2 was withdrawn at the onset of the secretory phase and samples
were collected after 14 days of P treatment alone. Samples were frozen in liquid
nitrogen for RNA isolation and TaqMan Real-time PCR analysis of MMP-26. Similar
samples were embedded in Tissue-Tek OCT (Miles Laboratories), frozen in liquid
propane, cryosectioned, and subjected to in situ hybridization (ISH) with macaque-
specific [35S]-labeled riboprobes to MMP-26. Samples were also fixed in 4%
paraformaldehyde, embedded in paraffin and analyzed by immunocytochemistry
(ICC) for MMP-26 with goat polyclonal anti-MMP-26 IgG or with monoclonal
antibodies to estrogen receptor alpha (ESR1) and progesterone receptor (PGR). Real-
time PCR confirmed that MMP-26 transcript was minimal during the mid and late
proliferative phase (n=9) and then increased .50 fold (P,0.001; n=4) by the mid
secretory phase of the cycle. MMP-26 mRNA levels significantly declined by .10
fold (P,0.001) on day 14 of P treatment. Mean MMP-26 levels further declined to
baseline during menses (P,0.01; n=8). ISH revealed that these striking changes in
MMP-26 mRNA were localized solely to the endometrial glands. Immunocyto-
chemistry showed that MMP-26 staining was absent in the glandular epithelium
during proliferative phase. By day 3 of P treatment (early secretory phase), MMP-26
staining was strong in glands of the functionalis zone. MMP-26 staining was maximal
on day 7 of P treatment and then declined in the late secretory phase. At this time
MMP-26 was minimal by ICC and ISH in 2 of 3 animals (n=6 total). Secretory phase
glands that retained MMP-26 immunoreactivity also retained staining for ESR1 and
PGR. Animals with E2 removed at the onset of the secretory phase showed no
immunoreactivity for ESR1, PGR, or MMP-26. We conclude that both E2 and P
action is required for expression of MMP-26, and that down-regulation of glandular
ESR1 by extended P action results in suppression of MMP-26 in the late secretory
phase. Supported by NIH grants HD18185 and RR000163 and the NIH Fogarty
International Center grant TW/HD-00668 (P. Michael Conn P.I.).
134. Anti-Proliferative Effects of Evodiamine and Rutaecarpine on
Human Ovarian Cancer Cell Line SKOV3. Ching-Han Yu, Ru-Cui Lin, and
Paulus S. Wang. Chung Shan Medical University, Taichung, Taiwan, Republic of
China; National Yang-Ming University, Taipei, Taiwan, Republic of China
Ovarian cancer is the fifth most common cancer among women in the United
States, and it causes more deaths than any other type of female gynaecological
malignancies. The human HER-2/neu-overexpressing ovarian cancer cells are
resistant to chemotherapeutic agent (Taxol). Therefore, there are almost no
efficacious therapeutic modalities for malignant ovarian cancer. It is important to
develop some new effective therapies. Evodiamine and rutaecarpine are quinazoli-
nocarboline alkaloids extracted from a kind of Chinese herb named Wu-Chu-Yu and
has been demonstrated to be effective in preventing the growth of a variety of cancer
cells, including downregulating the estrogen receptor of breast cancer. In the present
study, the mechanism by which evodiamine and rutaecarpine inhibited the HER-2/
neu-overexpressing ovarian cancer cell line SKOV3 was examined. Based on 3-(4,5-
dimethylthiazol-2-yle)2,5-diphenyltetrazolium bromide (MTT) assay, cell prolifera-
tion rate was reduced dose-dependently by evodiamine and rutaecarpine. According
to the flow cytometric analysis, evodiamine treatment resulted in G2/M arrest in
SKOV3 cells, but not rutaecarpine. Furthermore, by using the annexin V assay,
evodiamine- and rutaecarpine-induced apoptosis was observed at 48 hours and
extended to 72 hours. These results suggested that evodiamine and rutaecarpine
inhibited the growth and induced the cell apoptosis of the HER-2/neu-overexpressing
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